Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17715090 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL25695555 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL19049883 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL13497947 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL17586020 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL12923038 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL10050699 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL2287385 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL46479 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB | |
| SCHEMBL14308637 | 1.00 | HSD17B10 (0.36) | HSD17B10HTTMEN1KMT2ATHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130052130-A1 | Branched Discreet PEG Constructs | UNIVERSITY OF WASHINGTON (US) | 2013-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130052130-A1 | Branched Discreet PEG Constructs | BTD, DNPEP, IDUA | HSD17B10 979/4885HTT 3476/4885MEN1 3511/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.